Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Journal of Cardiovascular Pharmacology
|
July 19, 2022
The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis
Zibin Wang, Jin Su, Fanglin Gong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 7, 2016
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy
Yongju He, Zhigui Su, Lingjing Xue, et al.
Die Pharmazie
|
June 25, 2011
Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles
Xuefeng Jin, Aiwen Huang, Qineng Ping, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 5, 2020
Cytopharmaceuticals: An emerging paradigm for drug delivery
Weishuo Li, Zhigui Su, Meixi Hao, et al.
International Journal of Pharmaceutics
|
July 26, 2016
Size-exclusive effect of nanostructured lipid carriers on oral drug delivery
Huipeng Li, Minglei Chen, Zhigui Su, et al.
Expert Opinion on Therapeutic Targets
|
April 29, 2014
Emerging therapeutic targets for osteoporosis treatment
Minglei Chen, Hongzhi Qiao, Zhigui Su, et al.
Molecular Pharmaceutics
|
May 15, 2019
Cellular Vehicles Based on Neutrophils Enable Targeting of Atherosclerosis
Yanan Xue, Yue Wu, Qianqian Wang, et al.
Nanotechnology
|
October 30, 2010
Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo
Minjie Sun, Yu Wang, Jie Shen, et al.
ACS Applied Materials & Interfaces
|
July 16, 2016
Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles
Debin Yang, Tingfang Wang, Zhigui Su, et al.
International Journal of Pharmaceutics
|
October 12, 2010
Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution
Jie Shen, Yanping Deng, Xuefeng Jin, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Journal of Cardiovascular Pharmacology
|
July 19, 2022
The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis
Zibin Wang, Jin Su, Fanglin Gong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 7, 2016
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy
Yongju He, Zhigui Su, Lingjing Xue, et al.
Die Pharmazie
|
June 25, 2011
Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles
Xuefeng Jin, Aiwen Huang, Qineng Ping, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 5, 2020
Cytopharmaceuticals: An emerging paradigm for drug delivery
Weishuo Li, Zhigui Su, Meixi Hao, et al.
International Journal of Pharmaceutics
|
July 26, 2016
Size-exclusive effect of nanostructured lipid carriers on oral drug delivery
Huipeng Li, Minglei Chen, Zhigui Su, et al.
Expert Opinion on Therapeutic Targets
|
April 29, 2014
Emerging therapeutic targets for osteoporosis treatment
Minglei Chen, Hongzhi Qiao, Zhigui Su, et al.
Molecular Pharmaceutics
|
May 15, 2019
Cellular Vehicles Based on Neutrophils Enable Targeting of Atherosclerosis
Yanan Xue, Yue Wu, Qianqian Wang, et al.
Nanotechnology
|
October 30, 2010
Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo
Minjie Sun, Yu Wang, Jie Shen, et al.
ACS Applied Materials & Interfaces
|
July 16, 2016
Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles
Debin Yang, Tingfang Wang, Zhigui Su, et al.
International Journal of Pharmaceutics
|
October 12, 2010
Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution
Jie Shen, Yanping Deng, Xuefeng Jin, et al.
Page
of 6